Surgalign Holdings Alpha and Beta Analysis
| SRGADelisted Stock | USD 0.04 0 12.54% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Surgalign Holdings. It also helps investors analyze the systematic and unsystematic risks associated with investing in Surgalign Holdings over a specified time horizon. Remember, high Surgalign Holdings' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Surgalign Holdings' market risk premium analysis include:
Beta 1.96 | Alpha (3.55) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Surgalign |
Surgalign Holdings Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Surgalign Holdings market risk premium is the additional return an investor will receive from holding Surgalign Holdings long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Surgalign Holdings. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Surgalign Holdings' performance over market.| α | -3.55 | β | 1.96 |
Surgalign Holdings Fundamentals Vs Peers
Comparing Surgalign Holdings' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Surgalign Holdings' direct or indirect competition across all of the common fundamentals between Surgalign Holdings and the related equities. This way, we can detect undervalued stocks with similar characteristics as Surgalign Holdings or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Surgalign Holdings' fundamental indicators could also be used in its relative valuation, which is a method of valuing Surgalign Holdings by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Surgalign Holdings to competition |
| Fundamentals | Surgalign Holdings | Peer Average |
| Return On Equity | -14.97 | -0.31 |
| Return On Asset | -0.35 | -0.14 |
| Profit Margin | (0.65) % | (1.27) % |
| Operating Margin | (0.68) % | (5.51) % |
| Current Valuation | (7.93 M) | 16.62 B |
| Shares Outstanding | 9.18 M | 571.82 M |
| Shares Owned By Insiders | 17.15 % | 10.09 % |
Surgalign Holdings Opportunities
Surgalign Holdings Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Surgalign To Collaborate with Dr. Alexander Vaccaro and Dr. Pierce Nunley to Advance HOLO AI Insights and its Artificial Intelligence Technologies | 05/03/2023 |
2 | Payment of 541 shares by Terry Rich of Surgalign Holdings subject to Rule 16b-3 | 05/08/2023 |
3 | Surgalign Announces First Quarter 2023 Results and Provides Update on its Business Operations | 05/11/2023 |
4 | Surgalign to Participate at ISASS 2023 23rd Annual Conference Sponsored by the International Society for the Advancement of Spine Surgery and Medical Education ... | 05/23/2023 |
5 | Medtech firm Surgalign files for Chapter 11 bankruptcy | 06/20/2023 |
6 | Short Volatility Alert Surgalign Holdings | 06/26/2023 |
About Surgalign Holdings Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Surgalign or other delisted stocks. Alpha measures the amount that position in Surgalign Holdings has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Surgalign Holdings Upcoming Company Events
As portrayed in its financial statements, the presentation of Surgalign Holdings' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Surgalign Holdings' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Surgalign Holdings' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Surgalign Holdings. Please utilize our Beneish M Score to check the likelihood of Surgalign Holdings' management manipulating its earnings.
| 8th of August 2023 Upcoming Quarterly Report | View | |
| 1st of November 2023 Next Financial Report | View | |
| 30th of June 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 31st of March 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Surgalign Holdings
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Surgalign Stock
If you are still planning to invest in Surgalign Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Surgalign Holdings' history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |